Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/2930
|
| Title: | A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients |
| Authors: | Chi, KH;Chang, YC;Guo, WY;Leung, MJ;Shiau, CY;Chen, SY;Wang, LW;Lai, YL;Hsu, MM;Lian, SL;Chang, CH;Liu, TW;Chin, YH;Yen, SH;Perng, CH;Chen, KY |
| Contributors: | National Institute of Cancer Research |
| Abstract: | Purpose: To evaluate the role of adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma (NPC) patients we conducted a randomized Phase III trial comparing radiotherapy (RT) followed by adjuvant chemotherapy to RT alone in patients with advanced NPC. Methods and Materials: Between November 1994 and March 1999,157 patients with Stage IV, M-0 (UICC/AJCC, 1992) advanced NPC disease were randomized to receive standard radiotherapy, as follows: 35-40 fractions, 1.8-2.0 Gy/fraction/day, 5 days/week, to a total dose 70-72 Gy with or without 9 weekly cycles of 24-h infusional. chemotherapy (20 mg/m(2) cisplatin, 2,200 mg/m(2) 5-fluorouracil, and 120 mg/m(2) lencovorin) after RT. Of 157 patients enrolled, 154 (77 radiotherapy, 77 combined therapy) were evaluable for survival and toxicity analysis. Results: With a median follow-up of 49.5 months, the 5-year overall survival and relapse-free survival rates were 60.5% vs. 54.5% (p = 0.5) and 49.5% vs. 54.4% (p = 0.38) for the radiotherapy-alone group and the combined radiotherapy and adjuvant chemotherapy group, respectively. The Cox regression showed that the hazard rates ratio of combined treatment to RT alone was 0.673 (p value = 0.232); the 95% confidence interval was 0.352 and 1.288, respectively. Patients who received combined treatment had a lower systemic relapse rate than radiotherapy-alone patients, according to relapse pattern analysis. The incidence of leukopenia ( greater than or equal to Grade 3) occurred in 17 out of 819 (2.1%) cycles of weekly chemotherapy. No patient developed moderate to severe mucositis (greater than or equal to Grade 3). Conclusions: We conclude that adjuvant chemotherapy after RT for patients with advanced NPC has no benefit for overall survival or relapse-free survival. |
| Keywords: | Oncology;Radiology, Nuclear Medicine & Medical Imaging |
| Date: | 2002-04-01 |
| Relation: | International Journal of Radiation Oncology Biology Physics. 2002 Apr;52(5):1238-1244. |
| Link to: | http://dx.doi.org/10.1016/S0360-3016(01)02781-X |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0360-3016&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000174743200009 |
| Cited Times(Scopus): | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0036534902 |
| Appears in Collections: | [劉滄梧] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| 000174743200009.pdf | | 75Kb | Adobe PDF | 606 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
